Noble Wealth Management PBC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.4K Sell
421
-76
-15% -$3.52K 0.01% 402
2026
Q2
$21.2K Hold
497
– – 0.01% 386
2026
Q1
$31.2K Hold
497
– – 0.02% 315
2025
Q4
$47.4K Buy
497
+63
+15% +$6.18K 0.02% 272
2025
Q3
$42.4K Buy
+434
New +$44.9K 0.02% 265
2025
Q1
$48.1K Hold
477
– – 0.03% 215
2024
Q4
$42.6K Buy
+477
New +$42K 0.03% 213

Other funds holding BSX

Noble Wealth Management PBC's BSX Position: Q3 2026 in Review

Noble Wealth Management PBC reduced its Boston Scientific (BSX) stake by 15% in Q3 2026, selling an estimated $3.52K and leaving 421 shares worth $18.4K. The position accounts for 0.01% of the portfolio, ranked #402.

Noble Wealth Management PBC first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $48.1K in Q1 2025. 16 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Noble Wealth Management PBC held 421 shares of Boston Scientific worth $18.4K as of Q3 2026.
  • Noble Wealth Management PBC sold 76 Boston Scientific shares in Q3 2026, an estimated $3.52K.
  • Boston Scientific made up 0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #402 holding.
  • Noble Wealth Management PBC first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Noble Wealth Management PBC's Boston Scientific position peaked at $48.1K in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.